The pharmacology of parkinsonism (a review).
D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000502:physiology; D000818:Animals; D001532:Atropa belladonna / Q000627:therapeutic use; D001285:Atropine / Q000494:pharmacology; D002490:Central Nervous System / Q000502:physiology; D002746:Chlorpromazine / Q000009:adverse effects; D003913:Dextroamphetamine / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use; D004155:Diphenhydramine / Q000627:therapeutic use; D004296:Dopa Decarboxylase / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism / Q000502:physiology; D004357:Drug Synergism; D004837:Epinephrine / Q000378:metabolism; D006220:Haloperidol / Q000009:adverse effects; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D051379:Mice; D008995:Monoamine Oxidase / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010525:Peripheral Nerves / Q000502:physiology; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D012110:Reserpine / Q000009:adverse effects; D014282:Trihexyphenidyl / Q000627:therapeutic use
D006634:Histamine H1 Antagonists; D004295:Dihydroxyphenylalanine; D014282:Trihexyphenidyl; D001285:Atropine; D012110:Reserpine; D004155:Diphenhydramine; D008995:Monoamine Oxidase; D004296:Dopa Decarboxylase; D006220:Haloperidol; D000109:Acetylcholine; D003913:Dextroamphetamine; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine